Christopher Lafargue
Gynecologic Oncologist · University of Texas M D Anderson Cancer Center
Credentials: · · · · · · ·
History
- 2009–2013
Research
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Nature Genetics · 2009 · 790 citations
Exploring and comparing adverse events between PARP inhibitors
Review · The Lancet Oncology · 2019 · First of 4 authors · 413 citations
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
Nature Medicine · 2010 · 383 citations
- MR
10 papers
7 papers
5 papers
5 papers · 5 as a resident
- RC
5 papers
5 papers
4 papers
- GL
3 papers
